Lynn M. Schuchter, MD, chief of Hematology-Oncology at the Abramson Cancer Center, was quoted in an article in the San Francisco Chronicle on the promise of cancer vaccines. "There is a lot of excitement, and I would say it's sort of unprecedented what's happening in the cancer immunotherapy arena now," said Schuchter. What is driving the investment, she said, is scientists' increasingly deeper knowledge of how the immune system works. "What you're seeing are more approaches that attack the Achilles' heel of a cancer cell or combine different types of immunotherapies with a vaccine,” she said.
Read the San Francisco Chronicle article